Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

TNFSF14 Antikörper (AA 141-240) (PE)

TNFSF14 Reaktivität: Maus, Ratte WB, FACS Wirt: Kaninchen Polyclonal PE
Produktnummer ABIN740635
  • Target Alle TNFSF14 Antikörper anzeigen
    TNFSF14 (Tumor Necrosis Factor (Ligand) Superfamily, Member 14 (TNFSF14))
    Bindungsspezifität
    • 15
    • 8
    • 6
    • 6
    • 6
    • 5
    • 4
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 141-240
    Reaktivität
    • 57
    • 30
    • 22
    • 5
    • 4
    • 4
    • 1
    • 1
    Maus, Ratte
    Wirt
    • 65
    • 15
    • 1
    Kaninchen
    Klonalität
    • 67
    • 14
    Polyklonal
    Konjugat
    • 28
    • 11
    • 9
    • 5
    • 4
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser TNFSF14 Antikörper ist konjugiert mit PE
    Applikation
    • 59
    • 30
    • 27
    • 13
    • 13
    • 12
    • 7
    • 6
    • 5
    • 5
    • 3
    • 3
    • 2
    Western Blotting (WB), Flow Cytometry (FACS)
    Kreuzreaktivität
    Maus, Ratte
    Homologie
    Human,Dog,Cow,Pig,Horse,Rabbit
    Aufreinigung
    Purified by Protein A.
    Immunogen
    KLH conjugated synthetic peptide derived from human TNFSF14
    Isotyp
    IgG
    Top Product
    Discover our top product TNFSF14 Primärantikörper
  • Applikationshinweise
    FCM 1:20-100
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Konzentration
    1 μg/μL
    Buffer
    Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
    Konservierungsmittel
    ProClin
    Vorsichtsmaßnahmen
    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
    Lagerung
    -20 °C
    Informationen zur Lagerung
    Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
    Haltbarkeit
    12 months
  • Sibilano, Gaudenzio, DeGorter, Reber, Hernandez, Starkl, Zurek, Tsai, Zahner, Montgomery, Roers, Kronenberg, Yu, Galli: "A TNFRSF14-FcɛRI-mast cell pathway contributes to development of multiple features of asthma pathology in mice." in: Nature communications, Vol. 7, pp. 13696, (2016) (PubMed).

  • Target
    TNFSF14 (Tumor Necrosis Factor (Ligand) Superfamily, Member 14 (TNFSF14))
    Andere Bezeichnung
    TNFSF14 (TNFSF14 Produkte)
    Synonyme
    TNFSF14 antikoerper, CD258 antikoerper, HVEML antikoerper, LIGHT antikoerper, LTg antikoerper, TR2 antikoerper, HVEM-L antikoerper, Ly113 antikoerper, TNF superfamily member 14 antikoerper, tumor necrosis factor (ligand) superfamily, member 14 antikoerper, TNFSF14 antikoerper, Tnfsf14 antikoerper
    Hintergrund

    Synonyms: LTg, TR2, CD258, HVEML, LIGHT, Tumor necrosis factor ligand superfamily member 14, Herpes virus entry mediator ligand, HVEM-L, Herpesvirus entry mediator ligand, TNFSF14, UNQ391/PRO726

    Background: Cytokine that binds to TNFRSF3/LTBR. Binding to the decoy receptor TNFRSF6B modulates its effects. Activates NFKB, stimulates the proliferation of T-cells, and inhibits growth of the adenocarcinoma HT-29. Acts as a receptor for Herpes simplex virus.

    Gen-ID
    8740
    UniProt
    O43557
    Pathways
    Cancer Immune Checkpoints
Sie sind hier:
Kundenservice